Good morning, everyone, and nice to see you today. A clear, crisp day is emerging over the Pharmalot corporate campus, where we are engaging in our regular ritual of hustling assorted short people to their school houses. This marathon calls, of course, for a nice cup of stimulation and a bottle of water. We are two-fisted drinkers today. Meanwhile, there is much to be done. So let us begin. Here are some tidbits to start the day. Hope yours goes well and stay in touch...
Glaxo Insists R&D Returns Will Continue To Rise (Reuters)
Pfizer And Ranbaxy Sued For Anti-Competitive Lipitor Scheme (Bloomberg News)
Dogs May Hold Clues To Cures For Cancer (Wall Street Journal)
HIV Drugs Not Linked To Child Psychiatric Problems (Reuters)
Glaxo Halts Trials For Urinary Tract Infection Antibiotic (Pharma Times)
US DEA Raids Two Pharmacies In Drug Abuse Probe (Reuters)
Glaxo Earmarks $60M For Australian Plant (InPharm)
Merck Will Seek FDA OK For Insomnia Drug (Dow Jones)
Grocery Trade Group Criticizes Express Scripts-Medco Deal (Reuters)
Pfizer Breast Cancer Med Worsens Bone Loss In Older Women (Bloomberg News)
Daiichi Sankyo Eyes Acquiring Three Drugmakers (Economic Times)